The University of Delaware is seeking applications for several open rank tenure-track professorships as part of a multiyear hiring effort in the area of biopharmaceutical discovery. Applicants must have a doctoral or equivalent degree, documented evidence of high quality research productivity, and a strong commitment to both research and teaching. Applicants with research interests broadly relevant to biopharmaceutical discovery that span chemistry (e.g. chemoproteomics, molecular probes for biological imaging, metabolomics); biology (e.g. diseases of immune or tissue dysfunction) and engineering (e.g. synthetic biology, protein design, metabolic engineering) will be considered. Successful applicants could have faculty appointments in one or more of several departments, including Chemistry and Biochemistry, Biological Sciences, Chemical and Biomolecular Engineering, and Psychological and Brain Sciences.
Successful candidates are expected to: 1) develop and maintain a nationally recognized, externally funded interdisciplinary research program; 2) train BS, MS and PhD students; and 3) teach undergraduate and graduate level courses. Successful candidates may synergize with current university research efforts in immunology, chemical biology, protein engineering, synthetic biology, neuroscience, molecular mechanisms underlying human disease, genomics/metagenomics, microbiology, cellular and developmental biology, cancer biology, chemoproteomics, soft materials, cardiovascular biology, ophthalmology, musculoskeletal biology, and/or tissue engineering. Faculty will be provided with a competitive, ‘hard-funded’ salary and start-up package.
The University of Delaware, which is centrally located on the I-95 corridor between NYC/Philadelphia and Baltimore/Washington DC, has outstanding facilities and support, including a vibrant collaborative research and teaching community. The research environment is further strengthened by NIH-funded INBRE and Center for Translational Research Awards as well as several NIH-funded COBRE awards, including one focused on chemical biology (https://sites.udel.edu/cobrediscovery/). The University of Delaware administers several graduate programs with emphases in these areas including Chemical and Biomolecular Engineering, Chemistry and Biochemistry, Biological Sciences, Biomechanics and Movement Science, Materials Science, and Psychological and Brain Sciences. UD also hosts one of the longest running Chemistry-Biology Interface T32 training grants in the nation, which trains students in applying chemical approaches to life sciences research questions. The University offers a highly interactive multidisciplinary scientific environment with state-of-the-art core facilities in bioimaging, fMRI, genomics, bioinformatics, proteomics, mass spectrometry, nanofabrication, materials characterization, NMR, and small molecule X-ray crystallography (http://corefacilities.dbi.udel.edu/). UD also maintains robust clinical partnerships with Nemours/AI duPont Hospital for Children, which just built a clinical and research PET imaging facility, and The Helen F. Graham Cancer Center and Research Institute at Christiana Care. UD is also the host institution for the US Department of Commerce funded National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL; https://niimbl.org/index.php).